United States · FDA National Drug Code directory
Venlafaxine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-8774_3b13f051-c0d2-4c09-86f3-13c1c60fcf6b
- Product NDC
- 68788-8774
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Venlafaxine Hydrochloride
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241120
- Source listing expiry
- 20271231
Source-listed ingredients
- VENLAFAXINE HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68788-8774-1) · 68788-8774-1
- 20 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68788-8774-2) · 68788-8774-2
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68788-8774-3) · 68788-8774-3
- 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68788-8774-6) · 68788-8774-6
- 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68788-8774-8) · 68788-8774-8
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68788-8774-9) · 68788-8774-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →